FDA Advisory Committee Votes to Recommend Approval of Tetrabenazine

An advisory committee to the U.S. Food and Drug Administration (FDA) voted unanimously to recommend the approval of tetrabenazine, which would be the first drug approved in the United States to treat chorea associated with Huntington disease (HD).
BioSpace